<DOC>
	<DOCNO>NCT02388178</DOCNO>
	<brief_summary>This double blind , cross-over , control clinical trial utilize thirty ( 30 ) adult evaluate remineralization early caries lesion .</brief_summary>
	<brief_title>To Determine Ability New Product Formulation Remineralize Early Caries Lesion In-situ Study</brief_title>
	<detailed_description />
	<mesh_term>Dental Caries</mesh_term>
	<mesh_term>Fluorides</mesh_term>
	<criteria>1 . Male and/or female subject 18 50 year inclusive 2 . Minimum 20 natural uncrowned teeth ( exclude third molar ) must present 3 . Willing wear retainer 24 hour per day 4 . No active , unrestored cavity 5 . Have normal salivary flow rate ( stimulate unstimulated flow ≥0.7 ml/min ≥ 0.2 ml/min respectively ) ascertain preliminary sialometry 6 . Available throughout entire study 7 . Willing use assign product oral hygiene throughout duration study 8 . Must give write informed consent 9 . Must good general health 10 . No known history allergy personal care/consumer product ingredient , relevant ingredient test product determine dental/medical professional monitoring study 1 . Advanced periodontal disease 2 . Medical condition require premedication prior dental visits/procedures 3 . Not enough teeth secure oral retainer 4 . Diseases soft hard oral tissue 5 . Wear Orthodontic appliance 6 . Impaired salivary function 7 . Current use drug affect salivary flow 8 . Use antibiotic one ( 1 ) month prior study 9 . Pregnant breastfeed 10 . Participate another clinical study one ( 1 ) week prior start washout period 9week study period 11 . Use tobacco product 12 . Allergic common toothpaste ingredient 13 . Allergic amino acid 14 . Immune compromised individual ( HIV , AIDS , immunosuppressive drug therapy )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>February 2015</verification_date>
</DOC>